Gereis, Jessica http://orcid.org/0000-0003-3791-1660
Hetherington, Kate http://orcid.org/0000-0002-5457-5462
Ha, Lauren http://orcid.org/0000-0001-6494-5861
Robertson, Eden G. http://orcid.org/0000-0001-9395-7896
Ziegler, David S. http://orcid.org/0000-0001-7451-7916
Barlow-Stewart, Kristine http://orcid.org/0000-0003-1831-9944
Tucker, Katherine M. http://orcid.org/0000-0002-7180-6576
Marron, Jonathan M. http://orcid.org/0000-0001-8935-8524
Wakefield, Claire E. http://orcid.org/0000-0001-7704-7067
Funding for this research was provided by:
Luminesce Alliance – Innovation for Children’s Health, and Zero Childhood Cancer
Conquer Cancer/The ASCO Foundation, and the Dana-Farber Cancer Institute Division of Population Sciences
National Health and Medical Research Council of Australia
Article History
Received: 19 January 2022
Revised: 13 July 2022
Accepted: 26 July 2022
First Online: 23 August 2022
Competing interests
: JMM serves as a paid member of the Ethics Advisory Board for Partner Therapeutics and has received an honorarium for giving a lecture on ethical issues in oncology to employees of Sanofi-Genzyme Global Oncology. Neither of these entities had a role in the content or development of this paper.